CEO @CGOncology - developing bladder-sparing therapeutics for patients afflicted with bladder cancer
Joined June 2021
- Tweets 40
- Following 346
- Followers 227
- Likes 725
2 Photos and videos
Arthur Kuan retweeted
24 Jul 2023
@cgoncology completes patient enrollment in BOND-003 phase 3 monotherapy study with cretostimogene grenadenorepvec in BCG-unresponsive high-risk #NMIBC. #ReadNow details on UroToday > bit.ly/3q32dRo #BladderCancer @AndreaSMaddox16 @KuanArthur
3
4
876
Arthur Kuan retweeted
8 Jun 2023
New #JITC review: Vaccinating against cancer: getting to prime time bit.ly/3P0lP2t @gulleyj1 @lawfong
27
80
30,200
Arthur Kuan retweeted
1 May 2023
Updated results from #CORE1 using pembro cretostimogene (cg0070) in BCG unresponsive CIS
👉 Overall CR = 85% (29/34)
👉CR @ 12 months = 68% (17/25)
👉AE profile similar to monotherapy trials
@garysteinbergmd @UroDocAsh @tbivala1 @cgoncology
onclive.com/view/phase-2-dat…
4
14
57
8,552
Arthur Kuan retweeted
15 Nov 2022
Excited to announce our $120M financing co-led by Ori Capital, Longitude Capital and Decheng Capital. Proceeds to accelerate clinical programs across #bladdercancer including in the 1L setting, as the leading #urologic #oncology biotech! 🔥🔥
More info:
bwnews.pr/3X5Ochg
2
9
Arthur Kuan retweeted
24 Oct 2022
Looking forward to presenting new data from the CORE1 trial at #SITC2022. Join us in Oral Abstract session 105 on Thur, Nov. 10 at 11:55A in 258ABC @Praveen_IO @cgoncology @garysteinbergmd @UroDocAsh @MoffittResearch businesswire.com/news/home/2…
1
5
18
4 Aug 2022
Great work!
4 Aug 2022
5 yrs later, there is still confusion among sponsors about this issue !
Thanks @chana_weinstock @ElaineChangMD for clarifying this at excellent breakout session @BladderCancerUS #BCANTT22
@IBCG_BladderCA @IBCN1997
1
3
Arthur Kuan retweeted
22 Jun 2022
Everyone wants to make money or be an investor...
But most people don't speak the language of investing.
Here are 16 terms every VC knows but most investors don't:
173
1,338
6,825
Arthur Kuan retweeted
4 Jun 2022
Exciting prelim data from #CORE1 trial
👉92% (22/24) CR at 3mo
👉75% (6/8) CR at 12mo
👉Minimal irAE and SAE
Trial fully accrued, looking forward to final results! @cgoncology @garysteinbergmd @UroDocAsh @MoffittNews businesswire.com/news/home/2…
7
28
Arthur Kuan retweeted
12 Apr 2022
Happy to share very promising results from CORE-1 trial combining CG0070 and pembro for #BCGunresponsivedisease, presented by Dr. Uchio @ #AACR22! 14/16 CR, all 6 with durable response who reached 12mo! @garysteinbergmd @UroDocAsh @tbivala1 @pcvblack @KuanArthur @cgoncology
12 Apr 2022
Moffitt's @UrogerliMD shares results of the CORE1 Phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin at an #AACR22 mini-symposium at 2:50 pm today. abstractsonline.com/pp8/#!/1…
4
8
50
12 Feb 2022
Drug development is one of the hardest of all team sports. Big shout out to all drug developers out there! Never give up and always stay focused on your WHY. Without a clear purpose, it’s impossible to push ahead through challenging times.
1
8
Arthur Kuan retweeted
10 Dec 2021
A shout-out to everyone who wakes up day in and day out to slog it out developing drugs to help patients - scientists, entrepreneurs, operators, investors, investigators (& ppl who wear several of those hats). Drug dev't is HARD; taking on that challenge daily is to be applauded!
3
20
225
Arthur Kuan retweeted
3 Dec 2021
CG0070 Plus Pembrolizumab Yields Positive Preliminary Data in Non-Muscle Invasive Bladder Cancer cancernetwork.com/view/cg007…
1
2
16
14 Nov 2021
Congrats @UrogerliMD on the oral presentation at SITC 2021! Sincere appreciation to all patients who have participated thus far. Heading back to California now. Heads down focused execution. We will keep on pushing. @PatrickHwuMD
13 Nov 2021
Sharing this exciting #bladdercancer news at #SITC21 coming out of @cgoncology @KuanArthur - could be a game-changer for patients with limited to no options:
bwnews.pr/30kyxT6
2
3
8
Arthur Kuan retweeted
13 Nov 2021
Never-before-seen 100% 3-month CR rate in BCG-unresponsive NMIBC with systemic anti-PD-1 plus intravesical oncolytic virus presented by @UrogerliMD at #SITC21
5
12
65
Arthur Kuan retweeted
5 Nov 2021
Rule 7 Entrepreneurship in Biotechnology:
when pitching, the harder the questions, the better you’re doing (also: good VC vs evil VC)
@Columbia
3
3
52
Arthur Kuan retweeted
3 Nov 2021
📣 In the new episode of @PMedCast our host @yagensky sat down with @KuanArthur the CEO of @CGOncology to talk about #cancer, oncolytic #virus and building successful #biotech companies:
pmedcast.com/?p=2502
#PersonalizedMedicine #oncology #pharma
1
2
5
Arthur Kuan retweeted
28 Jul 2021
Discipline is when your long-term goals change your short-term behavior.
20
418
2,155
Arthur Kuan retweeted
22 Jul 2021
🚨New Podcast Alert🚨
@KuanArthur , CEO of @cgoncology , talks about the present and future of #bladdercancer therapies & how he’s committed to making a difference
🎙️ bit.ly/3wXMznC
#pharma #oncology #podcast #pharmaceutical #cancerresearch
1
6
6
Arthur Kuan retweeted
2 Jun 2021
CheckMate 274: Adjuvant nivolumab improves DFS in patients with high risk urothelial cancer post-curative intent surgery. @IcahnMountSinai @TischCancer @BladderCancerUS #blcsm @Uromigos @CancerResearch nejm.org/doi/full/10.1056/NE…
1
43
132